Pharma, Biotech and Generics Industry News | The Pharmaletter
5 days ago · The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results …
Pharmaceutical Industry News | The Pharmaletter
Nov 12, 2024 · The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results …
Pharmaceutical Generics Industry News | The Pharmaletter
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets.
Login - The Pharmaletter
4 days ago · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
About The Pharma Letter | The Pharmaletter
2 days ago · The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered …
Subscribe to The Pharma Letter | The Pharmaletter
3 days ago · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
FDA tests let military use expired drugs
Apr 5, 2000 · This article is accessible to registered users, to continue reading please register for free.. A free trial will give you access to exclusive features, interviews, round-ups and …
FDA drug regulation and approval news | The Pharmaletter
Nov 7, 2024 · Intercept Pharmaceuticals, now wholly owned subsidiary of Italy’s Alfasigma, today revealed that the US Food and Drug Administration (FDA) has issued a Complete Response …
Pharma and Biotechnology Events and Conferences | The …
Nov 16, 2024 · US clinical-stage biopharmaceutical company Boston Pharmaceuticals has announced positive results from a Phase II study evaluating the safety and efficacy of once …
USA Clears Ivermectin For Human Use - The Pharma Letter
Dec 2, 1996 · In the USA, the Food and Drug Administration has approved Merck & Co's Stromectil (ivermectin) for its first non-veterinary use, the chemotherapy of two parasitic …